The Supreme Court temporarily restored telehealth and mail access to the abortion pill mifepristone on Monday, responding to an emergency appeal that warned of potential chaos for patients who had appointments to access the drug.
The “administrative stay” is far from a final decision but rather maintains the status quo for a few days while the court reviews emergency appeals filed Saturday by the drug’s manufacturer and the maker of a generic version.
The order puts on hold a decision from the conservative 5th US Circuit Court of Appeals that reinstated a nationwide requirement that the medication be obtained in person, undermining access to the method of abortion that has grown more widespread since the court overturned Roe v. Wade.
|
